Squarepoint Ops LLC Sells 7,038 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Squarepoint Ops LLC lessened its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 4.2% in the second quarter, Holdings Channel.com reports. The firm owned 160,665 shares of the construction company’s stock after selling 7,038 shares during the period. Squarepoint Ops LLC’s holdings in Aspen Aerogels were worth $3,832,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently modified their holdings of the company. Cubist Systematic Strategies LLC purchased a new position in shares of Aspen Aerogels in the second quarter valued at $3,818,000. Point72 DIFC Ltd bought a new position in Aspen Aerogels in the 2nd quarter worth about $121,000. Marshall Wace LLP purchased a new position in Aspen Aerogels during the 2nd quarter valued at about $618,000. Public Employees Retirement Association of Colorado bought a new stake in shares of Aspen Aerogels during the second quarter valued at about $145,000. Finally, Seven Eight Capital LP bought a new stake in shares of Aspen Aerogels during the second quarter valued at about $2,511,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Price Performance

Shares of Aspen Aerogels stock opened at $26.06 on Wednesday. The firm has a market capitalization of $1.98 billion, a PE ratio of -59.23 and a beta of 2.16. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. Aspen Aerogels, Inc. has a 12 month low of $6.62 and a 12 month high of $33.15. The business’s 50-day moving average price is $25.20 and its 200-day moving average price is $23.73.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. The business had revenue of $117.80 million for the quarter, compared to analysts’ expectations of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The business’s quarterly revenue was up 144.4% on a year-over-year basis. During the same period last year, the business earned ($0.22) earnings per share. Sell-side analysts forecast that Aspen Aerogels, Inc. will post 0.21 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently commented on ASPN. Benchmark reaffirmed a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a research note on Thursday, August 8th. B. Riley upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th. Craig Hallum increased their price objective on Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, June 14th. TD Cowen boosted their target price on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Finally, Roth Mkm reaffirmed a “buy” rating and issued a $36.00 price target on shares of Aspen Aerogels in a report on Wednesday, August 21st. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $29.70.

Insider Buying and Selling

In other news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.